NDC 16729-047-01 - ATORVASTATIN CALCIUM
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-047
- Requested NDC
- 16729-047-01
- Package NDCs from labels
- 16729-047-10, 16729-047-15, 16729-047-01, 16729-047-16, 16729-047-17
- Manufacturer
- Accord Healthcare Inc. | Intas Pharmaceuticals Limited
- Effective date
- 2025-10-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ATORVASTATIN CALCIUM - Accord Healthcare Inc. | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2025-10-06 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - A-S Medication Solutions | A-S Medication Solutions | 2022-08-25 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - Bryant Ranch Prepack | Bryant Ranch Prepack | 2022-02-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-047-01 | ATORVASTATIN CALCIUM | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 13 | |
| 16729-047-10 | ATORVASTATIN CALCIUM | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 13 | |
| 16729-047-15 | ATORVASTATIN CALCIUM | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 13 | |
| 16729-047-16 | ATORVASTATIN CALCIUM | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 13 | |
| 16729-047-17 | ATORVASTATIN CALCIUM | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 13 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-047-15 | EA - Each | 16729-047 | 010cdd35-4a9f-46cb-9e88-e9b995a916e4 | 1 | 2021-06-02 |
| 16729-047-16 | EA - Each | 16729-047 | 8309dc33-7ab2-4f21-b01d-ec2dae00361f | 1 | 2018-08-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vitrexate | FOLIC ACID | PureTek Corporation | b34fee43-bea9-45b7-e053-2a95a90aad4d | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Vitrexate FE | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | b3637def-a701-673a-e053-2995a90a02d5 | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Venexa | FOLIC ACID | PureTek Corporation | ba130779-cdfd-086d-e053-2a95a90a2590 | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Venexa FE | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | ba142128-21c4-4204-e053-2a95a90ae0d7 | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Ribotin-E | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfcd-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Ventrixyl Fe | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | c7a626ec-88ec-d899-e053-2a95a90ab0ba | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Zintrexyl-C | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfca-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| EARACHE DROPS | BELLADONNA LEAF, CALCIUM CARBONATE, CHAMOMILE, LYCOPODIUM CLAVATUM SPORE, ANEMONE PATENS, AND SULFUR | Hyland's Inc. | 9b18453e-e338-4b8e-9856-85aca8c46ee1 | 2022-12-12 | Warnings | H0G9379FGK |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | Proficient Rx LP | a1b22973-cb9a-473e-a240-112b3e84e97c | 2022-12-01 | Warnings, Adverse reactions | ANDA207687 617311 48A5M73Z4Q |
| Refresh Digital PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | 97e83e68-6374-4df4-93f6-d707fc32748d | 2022-11-28 | Warnings | 6OZP39ZG8H |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | Proficient Rx LP | 44f0df8b-6069-4941-87e9-2c57c8dfddfa | 2022-11-28 | Warnings, Adverse reactions | 617311 617310 |
| Refresh Digital | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81 | 2022-11-28 | Warnings | 6OZP39ZG8H |
| OSTEOBIOS | CALCITONIN HUMAN - CALCIUM CARBONATE - CALCIUM FLUORIDE - CALCIUM PHOSPHATE - ISOLEUCINE - LEUCINE - LYSINE - METHIONINE - PHENYLALANINE - SUS SCROFA BONE - SUS SCROFA PARATHYROID GLAND - THREONINE - TRYPTOPHAN - VALINE - | Guna spa | 1b8c8c83-1a46-4c0a-b883-e7dce781c5d1 | 2022-11-14 | Warnings | H0G9379FGK |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | Proficient Rx LP | 957feff4-5005-4eea-bbe2-7232be65b0eb | 2022-10-01 | Warnings, Adverse reactions | 259255 |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | Proficient Rx LP | a34d3c72-ce91-47c7-86a1-f32caaed2c47 | 2022-10-01 | Warnings, Adverse reactions | 259255 48A5M73Z4Q |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | ebd0839e-2e1d-4e0e-986c-19f1f5c76358 | 2022-09-15 | Warnings | 6OZP39ZG8H |
| injoy heartburn relief | FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE | L. Perrigo Company | aca1b9e5-a35e-4eef-b55a-4189cd1b2a02 | 2022-09-07 | Warnings | H0G9379FGK |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | 6OZP39ZG8H |
| 6127c13c-d9cc-46b7-883d-ebd3df07cee9 | c4ec475d-8407-419c-b5e3-6b8dac17a79e | 2022-08-25 | Warnings, Adverse reactions | 6127c13c-d9cc-46b7-883d-ebd3df07cee9 c4ec475d-8407-419c-b5e3-6b8dac17a79e | ||
| signature care acid reducer complete | FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE | Safeway | 885f43ab-5c14-417b-aab7-e887dfc48f2e | 2022-07-20 | Warnings | H0G9379FGK |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.